Daihan Pharmaceutical Co.,Ltd. (023910.KQ)
KOSDAQ · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩25,200 (+0.00%) as of
Key statistics
- Market cap
- 148.18B
- Forward P/E
- 5.16
- Dividend yield
- 3.97%
- 52-week range
- 24,000.00 – 31,650.00
- Beta
- 0.15
- Revenue (TTM)
- 216.55B
- Profit margin
- 12.71%
- Analyst target
- ₩40,000
- Volume
- 5.39k
About Daihan Pharmaceutical Co.,Ltd.
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.